Afficher la notice abrégée
dc.creator | Ntaios G., Korompoki E. | en |
dc.date.accessioned | 2023-01-31T09:40:32Z | |
dc.date.available | 2023-01-31T09:40:32Z | |
dc.date.issued | 2022 | |
dc.identifier | 10.1016/j.ejim.2022.02.016 | |
dc.identifier.issn | 09536205 | |
dc.identifier.uri | http://hdl.handle.net/11615/77275 | |
dc.description.abstract | [No abstract available] | en |
dc.language.iso | en | en |
dc.source | European Journal of Internal Medicine | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124911139&doi=10.1016%2fj.ejim.2022.02.016&partnerID=40&md5=cc0c171007059a3055b0d5eaa4a22c3f | |
dc.subject | fibrinolytic agent | en |
dc.subject | cerebrovascular accident | en |
dc.subject | complication | en |
dc.subject | heart disease | en |
dc.subject | human | en |
dc.subject | secondary prevention | en |
dc.subject | Embolic Stroke | en |
dc.subject | Fibrinolytic Agents | en |
dc.subject | Heart Diseases | en |
dc.subject | Humans | en |
dc.subject | Secondary Prevention | en |
dc.subject | Stroke | en |
dc.subject | Elsevier B.V. | en |
dc.title | Embolic stroke of undetermined source and atrial cardiopathy: Towards a personalized antithrombotic strategy for secondary stroke prevention | en |
dc.type | other | en |
Fichier(s) constituant ce document
Il n'y a pas de fichiers associés à ce document.
|
Ce document figure dans la(les) collection(s) suivante(s)
Afficher la notice abrégée